Inventaire - your friends and communities are your best library

Minor clone provides a reservoir for relapse in multiple myeloma

published in: Leukemia

date of publication: 2012-08-09

main subject: multiple myeloma

Cites articles 32

Date

Title

Authors

2012-04-23

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

Jonathan J Keats, Sumit Middha, Rafael Fonseca
2012-04-12

Clonal competition with alternating dominance in multiple myeloma

Jonathan J Keats, Angela Dispenzieri, S. Vincent Rajkumar, Rafael Fonseca, Shaji K Kumar, P Leif Bergsagel, Scott A Van Wier, Esteban Braggio, John D Carpten, Marta Chesi, Victoria M Garbitt
2012-04-12

The genetic architecture of multiple myeloma

Gareth J Morgan, Brian A. Walker
2012-01-18

Clonal evolution in cancer

Melvyn Greaves
2012-01-11

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
2012-05-09

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.

Brian A. Walker, Christopher J Lord, Christopher P Wardell, Gareth J Morgan, Alan Ashworth, Iwanka Kozarewa, Kerry Fenwick, Sanna Hulkki, Lorenzo Melchor
2011-03-24

Initial genome sequencing and analysis of multiple myeloma

Eric Lander, Carrie Sougnez, Kristian Cibulskis, Gad Getz, Daniel Auclair, Wendy Winckler, Douglas Voet, Christina L. Harview, Louise M Perkins, Yotam Drier, Craig C Hofmeister, Trevor J Pugh, Stefano Monti, Rafael Fonseca, Sagar Lonial, Matthew Meyerson, Kenneth C. Anderson, Stacey Gabriel, Levi A Garraway, S. Vincent Rajkumar, Suzanne Trudel, Todd Golub, Andrey Sivachenko, William C Hahn, Anna C Schinzel, Bradley Bernstein, Andrzej Jakubowiak, Jonathan J Keats, Alex H Ramos
2011-02-14

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

Paul G. Richardson, Kenneth C. Anderson, Jacob P Laubach, Jake E Delmore, Constantine S Mitsiades, Sun Young Kong, Melissa Ooi, Steffen Klippel, Jana Jakubikova, Simona Blotta, Sophia Adamia, Merav Leiba
2011-02-03

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

Hervé Avet-Loiseau, Rafael Fonseca, Michele Cavo, Roman Hajek, Athanasios Dimopoulos, Jesús San Miguel, Robert A Kyle, Pieter Sonneveld, S. Vincent Rajkumar, Antonio Palumbo, Kenneth C. Anderson, Sundar Jagannath, Orhan Sezer, Nikhil V Munshi, Jean-Luc Harousseau, P Leif Bergsagel, International Myeloma Workshop Consensus Panel 1
2011-01-01

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells

Charles G. Mullighan, Jean Wang, John Dick
2011-02-16

The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells

Norma C. Gutiérrez, María-Belén Vidriales, Ramón García-Sanz, Jesús San Miguel, Bruno Paiva, Lucia Lopez-Corral, María Victoria Mateos, Ana Rasillo
2010-04-04

Mutation spectrum revealed by breakpoint sequencing of human germline CNVs

Benjamin P. Blackburne, Sarah J. Lindsay, Christine P Bird, Lira Mamanova
2010-09-07

Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial

Herve Avet-Loiseau, Philippe Moreau, Thierry Facon, Lotfi Benboubker, Gerald Marit, Pascal Lenain, Jean-Luc Harousseau, Mohamad Mohty, Michel Attal, Claire Mathiot, Marie Odile Petillon, Mauricette Michallet, Frederic Maloisel, Philippe Casassus
2010-12-15

Genetic variegation of clonal architecture and propagating cells in leukaemia

Melvyn Greaves, Anthony V. Moorman, Tariq Enver
2009-12-01

Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context

Kim H Orchard
2009-10-21

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Eastern Cooperative Oncology Group, S. Vincent Rajkumar, Rafael Fonseca
2009-10-01

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Rafael Fonseca, Norma C. Gutiérrez, Gareth J Morgan, Antonino Neri, Herve Avet-Loiseau, Stéphane Minvielle, Faith E Davies
2009-09-20

Prognostic significance of copy-number alterations in multiple myeloma

Hervé Avet-Loiseau, Florence Magrangeas, Loïc Campion, Philippe Moreau, Thierry Facon, Kenneth C. Anderson, Jean-Luc Harousseau, Stéphane Minvielle, Wilfried Gouraud, Michel Attal, Gerald Marit, Claire Mathiot, Nikhil V Munshi, Catherine Guérin-Charbonnel
2009-08

Mechanisms of change in gene copy number

James R. Lupski
2009-01-30

A microhomology-mediated break-induced replication model for the origin of human copy number variation

James R. Lupski
2008-11-01

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia

Charles G. Mullighan
2008-08-01

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

Ivan Špička, Athanasios Dimopoulos, Kudrat M Abdulkadyrov, Anna Dmoszyńska, Paul G. Richardson, Antonio Palumbo, Kenneth C. Anderson, Dixie-Lee Esseltine, Helgi van de Velde, Nuriet K Khuageva, Ofer Shpilberg, Olga S Samoilova, María Victoria Mateos, Andrew Cakana
2007-10-06

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Cyrille Hulin, Hervé Avet-Loiseau, Brigitte Pegourie, Carine Chaleteix, Ibrahim Yakoub-Agha, Thierry Facon
2007-08-01

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma

Rafael Fonseca, Rodger Tiedemann, Angela Dispenzieri, Barbara Bryant, Shaji K Kumar
2007-08-01

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

Bart Barlogie
2006-05-16

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transpla

Frits van Rhee, Bart Barlogie
2006-03-01

Thalidomide and hematopoietic-cell transplantation for multiple myeloma.

Somashekar G. Krishna, Bart Barlogie, Elias Anaissie, Maurizio Zangari, Frits van Rhee
2006-05-16

Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma

Brian A. Walker, Matthew Jenner, Gareth J Morgan
2005-09-30

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

Eric Lander, Jill P. Mesirov, Sayan Mukherjee, Todd Golub, Pablo Tamayo, Benjamin L. Ebert, Scott L Pomeroy
2004-02-10

dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data
2004-03-15

Characterization of clonogenic multiple myeloma cells

William Matsui
2002-03-01

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

Herve Avet-Loiseau, Thierry Facon

Article - wd:Q34147170

Welcome to Inventaire

the library of your friends and communities

learn more